美国 · SEC FORM 4
FRACTYL HEALTH, INC.
GUTS · Nasdaq · CIK 0001572616 · Healthcare · Biotechnology
内部人信号
5 位买方 · 6 条买入交易行 · $167.1K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Executive Officer, Chief Financial Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 73.7
- 73.5
- 73.5
- 73.3
- 73.1
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -42.7%
- 3M
- -51.7%
- 6M
- -19.9%
- 12M
- -73.7%
波动率与流动性
- 波动率
- 117.4%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- -1490.3%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,150,590
- 上期报告
- 2,696,513
- 日均成交量
- 1,793,632
- 回补天数
- 1.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | BRADLEY WILLIAM | 买入 (P) | Common Stock | 64,516 | USD 0.62 | USD 40,000 | SEC 申报 ↗ |
| 2026-06-12 | Royan Ajay | 买入 (P) | Common Stock | 23,000 | USD 0.85 | USD 19,550 | SEC 申报 ↗ |
| 2026-06-10 | Sheffield Ian | 买入 (P) | Common Stock | 35,000 | USD 0.73 | USD 25,550 | SEC 申报 ↗ |
| 2026-06-10 | Rajagopalan Harith | 买入 (P) | Common Stock | 25,000 | USD 0.73 | USD 18,250 | SEC 申报 ↗ |
| 2026-06-10 | BRADLEY WILLIAM | 买入 (P) | Common Stock | 68,493 | USD 0.73 | USD 50,000 | SEC 申报 ↗ |
| 2026-06-08 | Smith Weber Lara | 买入 (P) | Common Stock | 20,000 | USD 0.69 | USD 13,800 | SEC 申报 ↗ |
| 2025-12-04 | Rajagopalan Harith | 买入 (P) | Common Stock | 10,416 | USD 1.92 | USD 19,999 | SEC 申报 ↗ |
| 2025-03-14 | Royan Ajay | 买入 (P) | Common Stock | 17,901 | USD 1.28 | USD 22,913 | SEC 申报 ↗ |
| 2025-03-14 | Barnes Kelly Ann | 买入 (P) | Common Stock | 31,000 | USD 1.30 | USD 40,300 | SEC 申报 ↗ |
| 2025-03-13 | SCHULMAN AMY W | 买入 (P) | Common Stock | 8,550 | USD 1.17 | USD 10,004 | SEC 申报 ↗ |
| 2025-03-13 | Conaway Samuel | 买入 (P) | Common Stock | 8,550 | USD 1.17 | USD 10,004 | SEC 申报 ↗ |
| 2025-03-13 | BRADLEY WILLIAM | 买入 (P) | Common Stock | 16,129 | USD 1.26 | USD 20,323 | SEC 申报 ↗ |
| 2024-02-06 | Royan Ajay | 买入 (P) | Common Stock | 333,333 | USD 15.00 | USD 4,999,995 | SEC 申报 ↗ |
| 2024-02-06 | MITHRIL II LP; Mithril GP LP; Mithril II GP LP; Mithril II UGP LLC; Mithril LP; THIEL PETER | 买入 (P) | Common Stock | 333,333 | USD 15.00 | USD 4,999,995 | SEC 申报 ↗ |
| 2024-02-06 | Elia Marc; M28 Capital Management LP | 买入 (P) | Common Stock | 466,666 | USD 15.00 | USD 6,999,990 | SEC 申报 ↗ |
Form 4 申报证据
7 transaction lines in the latest 365-day window; 53 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | BRADLEY WILLIAM | 买入 (P) | Common Stock | 64,516 | USD 0.62 | USD 40,000 | SEC 申报 ↗ |
| 2026-06-12 | Royan Ajay | 买入 (P) | Common Stock | 23,000 | USD 0.85 | USD 19,550 | SEC 申报 ↗ |
| 2026-06-10 | Sheffield Ian | 买入 (P) | Common Stock | 35,000 | USD 0.73 | USD 25,550 | SEC 申报 ↗ |
展开近期 Form 4 证据 (7 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | BRADLEY WILLIAM | 买入 (P) | Common Stock | 64,516 | USD 0.62 | USD 40,000 | SEC 申报 ↗ |
| 2026-06-12 | Royan Ajay | 买入 (P) | Common Stock | 23,000 | USD 0.85 | USD 19,550 | SEC 申报 ↗ |
| 2026-06-10 | Sheffield Ian | 买入 (P) | Common Stock | 35,000 | USD 0.73 | USD 25,550 | SEC 申报 ↗ |
| 2026-06-10 | Rajagopalan Harith | 买入 (P) | Common Stock | 25,000 | USD 0.73 | USD 18,250 | SEC 申报 ↗ |
| 2026-06-10 | BRADLEY WILLIAM | 买入 (P) | Common Stock | 68,493 | USD 0.73 | USD 50,000 | SEC 申报 ↗ |
| 2026-06-08 | Smith Weber Lara | 买入 (P) | Common Stock | 20,000 | USD 0.69 | USD 13,800 | SEC 申报 ↗ |
| 2025-12-04 | Rajagopalan Harith | 买入 (P) | Common Stock | 10,416 | USD 1.92 | USD 19,999 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GUTS |
| CIK | 0001572616 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 53 transaction lines from 2024-02-06 to 2026-09-14 16 P purchase lines · 7 S sale lines · 30 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.